Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 27-sep-2026 · last seen 27-sep-2026

Type H Vessels and Angiogenic–Osteogenic Coupling

Current understanding

Type H vessels (CD31^hi/Emcn^hi capillaries in metaphyseal bone) couple angiogenesis to osteogenesis by supporting osteoprogenitors, and their density declines with age in parallel with bone loss [mechanism-plausible]. Myeloid angiogenic cells (MACs) — distinct from ECFCs — appear to support this niche partly through secreted extracellular vesicles, but the causal, human-translational evidence remains preclinical/review-level [expert-opinion]. Proposed engineering fixes (donor preconditioning, EV cargo loading, surface targeting, scaffold delivery) are pitched to overcome age-associated EV liabilities but have no clinical readouts yet [expert-opinion].

Evidence log

Open questions

Related

Contributing findings

pubmed review
Reprogramming the Aging Type H Vascular Niche via Myeloid Angiogenic Cell-Derived Extracellular Vesicles: Mechanisms, Engineering Strategies, and Translational Perspectives.
15-sep-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18